Profile | GDS4284 / 225478_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2420.06 | 86 |
GSM687648 | Patient 402 control | 1461.1 | 79 |
GSM687653 | Patient 403 control | 2053.83 | 84 |
GSM687658 | Patient 404 control | 1544.88 | 80 |
GSM687663 | Patient 411 control | 3324.04 | 90 |
GSM687668 | Patient 422 control | 1142.7 | 76 |
GSM687673 | Patient 424 control | 4490.16 | 93 |
GSM687678 | Patient 425 control | 1731.68 | 81 |
GSM687683 | Patient 427 control | 1114.27 | 75 |
GSM687688 | Patient 428 control | 3809.56 | 91 |
GSM687695 | Patient 441 control | 1819.86 | 84 |
GSM687699 | Patient 443 control | 1952.55 | 84 |
GSM687704 | Patient 444 control | 1113.78 | 76 |
GSM687707 | Patient 448 control | 1578.41 | 81 |
GSM687712 | Patient 449 control | 3002.32 | 89 |
GSM687719 | Patient 450 control | 1510.39 | 80 |
GSM687724 | Patient 451 control | 3260.94 | 90 |
GSM687728 | Patient 452 control | 859.767 | 72 |
GSM687646 | Patient 401 treated 24h | 2053.98 | 84 |
GSM687649 | Patient 402 treated 24h | 1430.82 | 79 |
GSM687665 | Patient 411 treated 24h | 3573.85 | 91 |
GSM687651 | Patient 402 treated 4 weeks | 1683.14 | 81 |
GSM687667 | Patient 411 treated 4 weeks | 3325.61 | 90 |
GSM687670 | Patient 422 treated 24h | 1180.73 | 76 |
GSM687671 | Patient 422 treated 4 weeks | 1097.27 | 75 |
GSM687654 | Patient 403 treated 24h | 2430.46 | 86 |
GSM687675 | Patient 424 treated 24h | 3764.25 | 91 |
GSM687685 | Patient 427 treated 24h | 1042.46 | 74 |
GSM687656 | Patient 403 treated 4 weeks | 2534.37 | 87 |
GSM687677 | Patient 424 treated 4 weeks | 4373.38 | 92 |
GSM687687 | Patient 427 treated 4 weeks | 1150.28 | 76 |
GSM687692 | Patient 428 treated 4h | 2662.91 | 87 |
GSM687716 | Patient 449 treated 4h | 3128.51 | 89 |
GSM687722 | Patient 450 treated 4h | 1305.71 | 78 |
GSM687680 | Patient 425 treated 24h | 1743.95 | 82 |
GSM687690 | Patient 428 treated 24h | 2696.7 | 87 |
GSM687700 | Patient 443 treated 24h | 1705.4 | 82 |
GSM687705 | Patient 444 treated 24h | 803.898 | 71 |
GSM687714 | Patient 449 treated 24h | 2624.92 | 87 |
GSM687721 | Patient 450 treated 24h | 1557.68 | 81 |
GSM687682 | Patient 425 treated 4 weeks | 1907.18 | 83 |
GSM687694 | Patient 428 treated 4 weeks | 3679.6 | 91 |
GSM687702 | Patient 443 treated 4 weeks | 2050.06 | 84 |
GSM687718 | Patient 449 treated 4 weeks | 3330.49 | 90 |
GSM687723 | Patient 450 treated 4 weeks | 1447.9 | 80 |
GSM687661 | Patient 404 treated 4h | 1206.09 | 77 |
GSM687710 | Patient 448 treated 4h | 1840.38 | 83 |
GSM687726 | Patient 451 treated 4h | 3179.49 | 89 |
GSM687730 | Patient 452 treated 4h | 1927.49 | 85 |
GSM687660 | Patient 404 treated 24h | 918.795 | 75 |
GSM687697 | Patient 441 treated 24h | 1293.1 | 78 |
GSM687709 | Patient 448 treated 24h | 1368.9 | 79 |
GSM687725 | Patient 451 treated 24h | 2938.71 | 89 |
GSM687729 | Patient 452 treated 24h | 562.057 | 66 |
GSM687727 | Patient 451 treated 4 weeks | 3174.98 | 89 |
GSM687731 | Patient 452 treated 4 weeks | 1241.72 | 77 |